Beam Therapeutics Inc. Quarterly Depreciation in USD from Q1 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Beam Therapeutics Inc. quarterly/annual Depreciation history and growth rate from Q1 2019 to Q4 2024.
  • Beam Therapeutics Inc. Depreciation for the quarter ending December 31, 2024 was $5.44M, a 1.51% increase year-over-year.
  • Beam Therapeutics Inc. Depreciation for the twelve months ending December 31, 2024 was $21.9M, a 9.56% increase year-over-year.
  • Beam Therapeutics Inc. annual Depreciation for 2024 was $21.9M, a 9.56% increase from 2023.
  • Beam Therapeutics Inc. annual Depreciation for 2023 was $20M, a 42% increase from 2022.
  • Beam Therapeutics Inc. annual Depreciation for 2022 was $14.1M, a 95.8% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $21.9M $5.44M +$81K +1.51% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-25
Q3 2024 $21.8M $5.48M +$288K +5.55% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $21.6M $5.58M +$760K +15.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $20.8M $5.43M +$784K +16.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $20M $5.36M +$1.42M +36% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-25
Q3 2023 $18.6M $5.19M +$1.71M +49.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $16.9M $4.82M +$1.4M +40.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $15.5M $4.65M +$1.39M +42.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $14.1M $3.94M +$1.41M +55.6% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-25
Q3 2022 $12.7M $3.47M +$1.8M +107% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $10.9M $3.42M +$1.82M +114% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $9.07M $3.26M +$1.86M +133% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $7.2M $2.53M +$1.26M +99.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $5.94M $1.68M +$457K +37.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $5.48M $1.59M +$449K +39.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $5.03M $1.4M +$298K +27.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $4.74M $1.27M +$270K +26.9% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $4.47M $1.22M +$310K +34.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $4.16M $1.15M +$287K +33.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $3.87M $1.1M +$365K +49.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $3.5M $1M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $908K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $858K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $735K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.